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Despite advances in the management of peripheral arterial occlusive disease, 
acute embolism of the lower extremities is still characterized by an important limb 
threat, morbidity, mortality, and continues to pose a challenge to the vascular 
surgeon. Atrial fibrillation, left ventricular aneurysm, penetrating ulcers or aneu-
rysms of the aorta and common iliac arteries are the common sources of emboli. 
The presence of occlusion can be determined noninvasively with the use of duplex 
Doppler ultrasonography. Arteriography, Computed Tomographic Angiography 
and Magnetic Resonance Angiography can also be employed. Embolectomy is the 
standard for acute leg ischemia in patients with a strong clinical suspicion of an 
embolus, but alternative techniques, such as catheter-directed thrombolysis or 
percutaneous aspiration thrombolectomy, expand the role of radiologic percutane-
ous therapy of the acutely ischemic limb.
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1. Introduction
Acute limb ischemia results from a sudden decrease in limb perfusion that 
threatens limb viability and often requires urgent revascularization [1]. Acute 
ischemia of the lower limb continues to pose a challenge to the vascular surgeon and 
is still characterized by an important morbidity, limb threat and mortality. The two 
principal etiologies of acute ischemia of the lower limbs are arterial embolism and 
in situ thrombosis of an atherosclerotic artery or of a bypass graft [2]. It is estimated 
that the incidence of acute limb ischemia in the general population is around 
14/100,000 inhabitants per year [3].
The consequences of acute limb ischemia such as prolonged hospitalization, 
major limb amputation, and/or death have a profound socioeconomic impact. Acute 
limb ischemia represents a high-risk cohort in need of complex revascularization 
procedures that are often associated with a significant rate of periinterventional 
complications [4]. Historic rates of amputation and mortality range from 10 to 25%, 
emphasizing the need for prompt evaluation and treatment [5, 6].
Embolism is the result of material passing through the arterial tree and obstruct-
ing a peripheral artery [7]. These materials may be thrombi, fragments of athero-
matous plaque, tumor cells, or other foreign bodies, that have been dislodged or 
introduced into any part of the arterial system and can cause partial or total occlu-
sion of an artery at a point distant from where they originated [8].
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The arteries most commonly affected in the lower limbs are the femoral, the 
popliteal, the iliac, and the aorta [9–13]. The most frequent site of involvement is 
the femoral bifurcation, accounting for 35–50% of cases [14–17].
The approach of the arterial embolism of the lower limb has evolved signifi-
cantly in the past decade, especially regarding the development of endovascular 
treatment.
2. Etiology
The heart has been described as a source of emboli with frequency in the range 
of 78–96% [12, 18]. When emboli originate in the heart, more than 70% will 
obstruct the lower limbs, including those lodged at the bifurcation of the aorta [19]. 
The majority of emboli originate in the heart, primarily the left heart, as a result of 
fragmentation of intracavitary thrombi [15, 16].
Atrial fibrillation, left ventricular aneurysm, penetrating ulcers or aneurysms 
of the aorta and common iliac arteries are the common sources of emboli. Nearly all 
emboli arise from the left heart, aorta, and iliac vessels. A minority are paradoxi-
cal venous emboli that pass through an intracardiac shunt. Emboli typically lodge 
at branch points in the vascular tree and occlude both tributaries [20]. The most 
frequent cause of formation of these thrombi is atrial fibrillation, which occurs in 
mitral valve lesions of rheumatic origin, hyperthyroidism, acute myocardial infarc-
tion, and cardiosclerosis. The hemodynamic changes caused by atrial fibrillation, 
causing formation of mural thrombi, is the most important source of emboli [16, 21]. 
Autopsy studies of heart patients with and without atrial fibrillation showed that the 
frequency was much higher in the first group [22].
The most frequent cause of emboli among the valve disorders is mitral valve 
disease, primarily mitral stenosis of rheumatic origin. Thrombi may develop in the 
subvalvar area, but frequency is greater in the left atrium. Among these patients, 
two factors appear to be intimately linked with the embolic episode: age and 
presence of atrial fibrillation [21]. In the past, cardiac valve disease was the main 
cause of arterial embolism, but advances in the management of these patients have 
virtually eliminated this as a cause [23–25].
Patients with transmural myocardial infarction are at risk of embolization for 
3–4 weeks after the acute event. The majority of these thrombi form in the left 
ventricle (the region most often involved in myocardial infarctions). Systemic 
embolization can occur after 5% of after acute myocardial infarction cases [17]. In 
patients with heart failure, the left atrium or the left ventricle may form thrombi, 
causing systemic emboli [8].
Another cause of emboli is intracardiac tumors. The tissue of these tumors may 
dislodge from the heart, causing distal emboli [26].
Acute or subacute bacterial endocarditis can cause arterial emboli, from deposits 
built up on the valve itself, or by encouraging formation of thrombi. In these cases, 
the arteries obstructed are generally those of narrower caliber [27].
Nowadays, invasive diagnostic, therapeutic procedures and cardiovascular 
surgery constitute an important iatrogenic source of peripheral emboli [28, 29]. 
Thromboembolic complications, including systemic emboli, occur at a rate of 
0.7–6% patient-years in thrombosis of mechanical valves [30].
While rare, it is possible for a venous embolus to reach the arterial circulation, 
causing acute arterial occlusion (paradoxical embolism). In such cases, a thrombus 
with origin in peripheral veins crosses over to the arterial circulation when the 
patient has a persistent foramen ovale or intracardiac shunt or there is reversal of 
the pressure gradients between right and left heart chambers [31].
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Cholesterol embolization syndrome (atheroembolism) refers to embolization 
of the contents of an atherosclerotic plaque (primarily cholesterol crystals) from a 
proximal large-caliber artery to distal small to medium arteries causing end-organ 
damage by mechanical plugging and an inflammatory response [32]. Embolization 
of cholesterol crystals from ulcerated atherosclerotic plaques is well known. 
Disseminated cholesterol emboli may produce a systemic illness with livedo reticu-
laris of the lower limbs and splinter hemorrhages of the nails [33]. Atheroembolism 
leads to multifocal ischemic lesions and progressive tissue loss [34] (Figure 1). It 
occurs predominantly in elderly men with a history of atherosclerotic disease and 
hypertension [35]. Lesions of differing ages were found in individual cases, sug-
gesting that the process of embolism was recurrent [33]. They can occur spontane-
ously, but are more common after trauma, endovascular procedures, open vascular 
surgery, thrombolysis, and anticoagulation [36, 37]. Extra-cardiac emboli are very 
often associated with aortic, iliac, femoral, and popliteal aneurysms. They occur in 
5–10% of cases [38].
Tissues’ resistance to anoxia is dependent on several factors, which includes meta-
bolic requirements and the effectiveness of collateral circulation [39]. The peripheral 
nervous system is affected first [40], and therefore loss of sensation is one of the earli-
est signs of acute leg ischemia [7], the skeletal musculature is affected soon afterwards, 
and irreversible damage can occur after 6 h of ischemia. The skin, subcutaneous tissue, 
bone tissues, and cartilage have greater resistance to ischemia [40]. This is why muscle 
tenderness is one of the end-stage signs of acute leg ischemia [7] Table 1 shows the 
lower limb emboli sources.
Figure 1. 
Atheroembolism.
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3. Clinical assessment
The symptoms caused by vascular occlusion depend on the size of the artery 
occluded and whether collaterals have developed beforehand [7]. The classic 
description of acute occlusion of a lower limb artery is of acute pain with sudden 
onset, cyanosis, paresthesia, paralysis, cold, pallor, and absent pulses distal to the 
site of occlusion (Figure 2). The symptoms of paresis, hypoesthesia, or even paraly-
sis are related to ischemic damage to nerve fibers. The segment distal to the occlu-
sion will exhibit pallor of variable extent and intensity, intensifying when the limb 
is raised. In the majority of cases of acute arterial occlusion, pulses distal of the site 
of occlusion are absent, but in rare cases they may be present because of collateral 
circulation. In this patients, onset of pain may be more insidious and pain may be 
less intense [8]. Therefore, sudden occlusion of a proximal artery without existing 
collaterals leads to an acute white leg, whereas occlusion of the superficial femoral 
artery in the presence of well-established collaterals may be asymptomatic [7].
Handheld Doppler examination is also a basic part of the examination. The presence 
of normal biphasic signals excludes the diagnosis. Pedal arterial signals may be absent 
or reduced. Soft monophasic signals are associated with patent distal vessels but proxi-
mal arterial occlusion. Absent Doppler signals in the ankle arteries is a poor prognostic 
sign. In severe ischemia, ankle Doppler pressures are impossible to measure. In patients 
Figure 2. 
Clinical assessment of acute arterial embolism of the lower limb.
Cardiac
1. Atrial fibrillation








1. Aorta-iliac penetrating ulcers
2. Aneurysms of the aorta, iliac, femoral, and popliteal arteries
3. Iatrogenic (invasive diagnostic, therapeutic procedures, cardiovascular surgery, thrombolysis 
and anticoagulation)
4. Cholesterol embolization syndrome (atheroembolism)
5. Trauma
Table 1. 
Lower limb emboli sources.
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with severe ischemia, irreversible muscle necrosis occurs within 6 h if the condition 
is untreated [7]. The severity of limb ischemia at the time of admission to the hospital 
seems to be a more important factor in limb salvage than the time interval between 
embolic episode and operation. Even after long delay, if the limb appears to be viable on 
examination, the probability exists for a successful operation. This is due to adequate 
collateral circulation supplying the extremity until the blockage is removed [41].
It is difficult to determine by clinical examination the limits of reversibility of 
lower limb ischemia. Tissue viability tests should be performed. Rutherford et al. 
[42], proposed a clinical classification of acute limb ischemia comprising 3 groups 
in an attempt to establish parameters to define treatment (Table 2). Three general 
classes are recognized:
Class I: Non-threatened extremity; elective revascularization may or may not be 
necessary.
Class II: Threatened extremity; revascularization is indicated to prevent  
tissue loss.
Class III: Ischemia has progressed to infarction and salvage of the extremity is 
not possible.
The most lethal form of acute arterial embolism is emboli of the aortic bifurca-
tion, with symptoms in both lower limbs and in some cases spinal ischemia caused 
by involvement of lumbar arteries [43].
4. Complementary exams
When time permits, some methods can be used to definitively determine the site 
and nature of the arterial occlusion. Investigation may be valuable in confirming 
the clinical diagnosis and planning the treatment for patients with acute ischemia. 
The modern treatment in a hybrid operating room with access to the full range of 
surgical and interventional procedures is the best approach. Unfortunately, some-
times there may be no time for investigation [7].
4.1 Ultrasound
The Doppler Ultrasound exam can be employed in cases of acute ischemia to 
define the level of the arterial occlusion and the patency of other vessels [7]. It can 
Category Description/prognosis Findings Doppler signals
Sensory loss Muscle 
weakness
Arterial Venous
I. Viable Not immediately threatened None None Audible Audible
II. Threatened





b. Immediately Salvageable with immediate 
revascularization






III. Irreversible Major tissue loss or 









Clinical categories of acute limb ischemia.
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Figure 3. 
Angiotomography demonstrating acute arterial embolism in the origin of the left external iliac artery (arrow).
also provide information that confirms diagnosis and occasionally reveals concur-
rent venous thrombosis. Detection of distal flow at pressures exceeding 50 mmHg 
confirms significant collateral circulation, demonstrating that additional time is 
available to conduct a more thorough evaluation of the case [8]. Portable ultrasound 
machines may permit rapid, bedside imaging by vascular specialists trained in 
duplex imaging [7].
4.2 Computed tomographic angiography (CTA)
CTA has become the exam of choice for urgent investigation of acute arterial 
ischemia [7]. It provides good quality images, offering the possibility of three-
dimensional reconstruction, and is of similar quality to angiography [8] (Figure 3). 
A new-generation computed tomography scanners acquire images at very high speed 
and are available in most emergency suites. The images sometimes require manipu-
lation to produce the best results. These images are particularly good for aortoiliac 
occlusions but give adequate information to plan treatment of infrainguinal occlu-
sions [7]. It has the disadvantage of using iodine contrast, which restricts use of this 
examination with patients allergic to iodine or with pre-dialysis chronic stage of 
renal insufficiency [8]. In these cases, intravenous fluids should be considered for 
prehydration [7].
4.3 Arteriography
Arteriography was the mainstay of investigation for acute leg ischemia, but it 
is less accessible than CT angiography in many hospitals without a hybrid opera-
tion room [7]. It should be chosen in selected cases with viable extremities, in 
which it will not delay treatment. Immediately threatened patients should undergo 
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embolectomy at once, conducting arteriography intraoperatively. This examination 
can reveal the embolic or thrombotic nature of the obstruction in a large number of 
cases [8]. Brachial puncture can be used in the absence of femoral pulses. The arte-
riography documents the level of occlusion and sometimes its nature. Sometimes 
emboli can be seen in several vessels, establishing the diagnosis.
Arteriography may not visualize all the distal vessels in the acute situa-
tion, because the lack of collaterals and associated spasm limit visualization. 
Angiography is the best choice when an endovascular solution to the arterial 
occlusion is likely, because thrombolysis, percutaneous thrombectomy, angioplasty, 
or stenting can be performed during the same operative session. It may still be 
worth exploring distal vessels surgically when contemplating a distal bypass in this 
situation [7].
There are angiographic signs suggestive of emboli: a filling defect at the level of 
the occlusion, normal artery wall, poor or absent collateral circulation, and occlu-
sive involvement at bifurcations [8].
4.4 Magnetic resonance angiography (MRI)
It has not yet fully established the point MRI can be used to substitute conven-
tional angiography (which remains the gold standard diagnostic examination) or 
angiotomography, which offers better results in cases with calcified atherosclerotic 
plaque [8]. MRI has the advantage to produce an image, without the need of ion-
izing radiation or nephrotoxic contrast agents [44].
Magnetic resonance angiography with gadolinium is less useful than either CT 
or ultrasound in the acute limb ischemia. It takes time to acquire images, and is 
generally inconvenient [7].
4.5 Echocardiography
The echocardiography can be omitted when a cardiac source of embolism 
appears from the clinical setting [45]. In practical terms, the investigation rarely 
alters management, because most patients are anticoagulated for life after suc-
cessful treatment for acute ischemia. There are certainly some conditions that 
require echocardiography to make a diagnosis, such as valvular disease (includ-
ing vegetations), septal defect, and cardiac tumor. Problems associated with the 
routine application of echocardiography include the variability in results between 
transthoracic and transesophageal techniques, the inability to visualize the left 
atrial appendage, the fact that failure to visualize the source of an embolus does not 
rule out its existence, and the test’s lack of influence on overall management [46]. 
A practical view would be that echocardiography is indicated in young patients, 
those in whom a cardiac diagnosis is suspected, and those in whom the results might 
affect decisions about long-term anticoagulation [7].
4.6 Laboratory tests
Muscle ischemia is accompanied by a considerable increase in creatine phospho-
kinase (CPK). The elevation is so marked that for a long time it was considered that 
CPK level was a determinant of the degree of ischemia and of prognosis of recovery 
of the ischemic limb after revascularization. The level of leukocytes in circulation 
may also increase [47]. LDH and SGOT levels are also increased in cases of acute 
arterial occlusion, because of the ischemic insult to skeletal musculature. Some 
authors recommend testing levels of LDH, CPK and their respective isozymes in 
these patients [48, 49].
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5. Treatment
Once the initial assessment is complete, a decision should be made about the 
intervention required and its timing. The threat to the limb escalates with secondary 
thrombosis of underperfused distal vessels, particularly in patients with emboli. 
The following options are available: anticoagulation alone, operative intervention, 
and endovascular intervention via mechanical thrombectomy or thrombolysis 
[7]. A distinction between subacute (class I) and true limb-threatening ischemia 
(classes IIa, IIb and III) becomes relevant regarding the urgency of care and risk of 
limb loss [50].
The choice of intervention depends on the available expertise and the severity of 
the leg ischemia [1]. There is a suggestion that endovascular first treatment may be 
more expensive overall [51], but even in modern series, open vascular reconstruc-
tion for acute limb ischemia carries a significant risk of major morbidity (20%) or 
limb loss (22%) [52].
5.1 Auxiliary measures
In patients with there is risk of renal dysfunction, so an intravenous infusion 
of fluid is appropriate [7]. Other first-aid measures that are beneficial in patients 
with leg ischemia include the use of oxygen. This has been shown to improve skin 
perfusion, even in the ischemic limb [53]. A blood sample is indicated. In patients 
with recurrent thrombosis, a full thrombophilia screen should be performed at this 
stage [54, 55]. These tests are indicated in patients with a strong family history of 
arterial and venous thrombosis or those with recurrent disease [56, 57]. Analgesics 
and sedatives are also employed for pain relief [8].
5.2 Anticoagulation
Heparin should be administered as soon as possible when the acute arterial 
occlusion has been diagnosed. This drug prevents secondary thrombosis and venous 
thrombosis that may be present from advancing, both of which are factors that 
worsen prognosis [58, 59]. Use of anticoagulation alone as a treatment implies that 
the limb is likely to remain viable or that other therapeutic options are limited, 
perhaps by age or comorbidity. The anticoagulants made an immediate impact in 
the morbidity and mortality rates after their introduction [60, 61].
Whereas low-molecular-weight heparin is a valuable therapy for many condi-
tions, the potential for reversal with protamine makes calcium heparin the drug 
of choice in this situation [7]. The majority of authors recommend intravenous 
administration of calcium heparin in bolus at a dosage of 5000–10,000 units  
[58, 59]. In patients in whom definitive treatment is deferred an intravenous heparin 
infusion (18 U/kg/h) should be prescribed [62].
5.3 Thromboembolectomy
After Fogarty et al. described the embolectomy catheter for the remote removal 
of a clot via a groin incision in 1963, surgery became the main treatment for acute 
leg ischemia [63]. The arterial thromboembolectomy is an efficient treatment for 
acute arterial thromboemboli of lower limbs, especially if a single large artery 
is involved. Unfortunately, residual thrombus, propagation of thrombi, chronic 
atherosclerotic disease, and vessel injuries secondary to balloon catheter passage 
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While the time elapsed between the embolic episode and effective treatment is 
an important prognostic factor, experience has shown that good results can still be 
achieved even with late thromboembolectomy, as long as the limb is viable [11, 65]. 
The most appropriate access for aortoiliac, femoral, popliteal emboli is the com-
mon femoral artery at the femoral triangle (bilaterally for emboli of the aorta) [17] 
(Figure 4). Embolectomy is less likely to be effective for distal occlusions [8].
The benefits of open surgical embolectomy are rapid restoration of blood flow 
and the ease of the procedure, whereas the risks include a greater physiological 
stress and concomitant blood loss [50].
5.4 Thrombolysis
Unlike surgical embolectomy, thrombolysis lyses clot in both large and small 
arteries and arteriolar and capillary beds [66].
Low dose intra-arterial fibrinolytic therapy treatment has its place as an alterna-
tive to surgical treatment of acute embolic occlusions in selected cases [67, 68]. 
The recommendation for intra-arterial thrombolysis is applicable to patients with 
embolic acute arterial occlusion of less than 14 days duration and with sufficient 
collateral circulation to maintain limb viability for 12 h [69, 70].
Currently available agents include alteplase (rt-PA), reteplase (rPA), and 
tenecteplase (TNK). The bolus is delivery of a single concentrated dose of thrombo-
lytic agent throughout the occlusion and then the continuous infusion is initiated. 
Pulse spray refers to repeated forceful injection of thrombolytic, thus distributing 
the agent rapidly throughout the thrombus.
Figure 4. 
Embolectomy in lower limb: (A) exposure of the femoral arteries and arteriotomy; (B and C) introduction of 
the Fogarty catheter for thrombus removal; and (D) thrombi removed from the arterial system.
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The commonly used doses today are Alteplase (rt-PA): continuous, 0.5–1.0 mg/kg/h  
(40 mg maximum); bolus, 2–5 mg bolus, then continuous infusion; pulse spray, 
0.5 mg/mL at 0.2 mL every 30–60 seconds, Reteplase (rPA): continuous, 0.25–0.5 U/h 
(20 units maximum); bolus, 2–5 U bolus, then continuous infusion and Tenecteplase 
(TNK): continuous, 0.125–0.25 mg/h; bolus, 1–5 mg, then continuous infusion (20).
Streptokinase, the first-generation agent, is still used in some centers. This drug is 
used intra-arterially, by continuous infusion through a multiperforated catheter, posi-
tioned immediately before the obstruction, with release of the thrombolytic inside the 
thrombus, activating plasminogen bound to it [71]. This technique made it possible to 
use streptokinase at much lower doses, reducing the risk of hemorrhage, while main-
taining its thrombolytic power. The dose used is 5000 UI/h, controlling coagulation 
status every 12 h by fibrinogen assay, TP, and TTPA, attempting not to allow fibrino-
gen to fall below 100 mg%. Good results are achieved using this technique [72–74], 
although there are hemorrhagic complications in up to 20% of cases [59]. The infusion 
is then maintained at a dosage of 1 mg/h and the patient is kept anticoagulated with 
unfractionated heparin on a continuous infusion pump [8]. Heparin can be infused 
intravenously or intra-arterially through the sheath. A bolus at the time of thromboly-
sis initiation is not recommended. An infusion rate to raise PTT to only 1.25–1.5 of 
control is recommended. Most practitioners use between 200 and 500 U/h [20].
Some prospective and randomized studies compared direct thrombolysis 
with surgical revascularization in cases of acute arterial occlusion and the two 
approaches were not different for limb salvage or mortality, but fibrinolysis was 
associated with a higher risk of hemorrhagic events [66, 75–77].
5.4.1 Contraindications to thrombolytic therapy
Many patients with acute limb ischemia are not candidates for thrombolysis 
because of excessive major bleeding risks. All major and minor contraindications 
should be viewed in the context of the clinical circumstance. The increased risk of 
bleeding complications may be assumed if the alternative is likely limb loss or death 
[20]. Table 3 lists thrombolytics contraindications [78].
When using thrombolytics, arteriography should be performed every 6 h, or 
in the event of changes to the patient’s clinical. Fibrinogen assay also should be 
performed every 6 h. If the results of these tests are undesirable, fibrinolytic agent 
should be suspended [8].
The criteria for successful thrombolysis are radiological evidence of lysis with 
arterial recanalization at least as far as the next major collateral, an increase in the 
ankle brachial index greater than or equal to 0.2, limb salvage at 30 days without 
recourse to reconstructive surgery at the level at which lysis was performed and no 
clinical evidence or rethrombosis within the first 30 days [79].
5.5 Percutaneous aspiration thrombectomy
The treatment of the arterial embolism of the lower limb has evolved signifi-
cantly, especially regarding the development of endovascular devices.
Percutaneous aspiration thrombectomy is another resource that offers and is an 
alternative to surgical treatment and can be combined with angioplasty or fibri-
nolytic therapy [80, 81]. These materials generally employ simple mechanisms for 
aspiration or destruction of the thrombus [82].
Promising results were obtained for percutaneous mechanical thrombectomy, 
employing a range of different equipment [81, 83–86]. The trend is that endovascu-
lar treatment significantly evolves, with the development of new and less invasive 
of these devices.
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6. Postoperative anticoagulation
Postoperative anticoagulation is recommended long term and, sometimes, even 
indefinitely, in cases of atrial fibrillation and arterial emboli in which the source 
of origin is not identified or is not controlled [11]. One study demonstrated 31% 
recurrence of emboli in patients not taking anticoagulants during the postoperative 
period vs. 9% among those taking anticoagulants [16].
New drugs are currently used for postoperative anticoagulation, mainly factor 
Xa inhibitors. There are evidences to justify its use, in order to prevent recurrent 
episodes.
7. Postoperative complications
High operative mortality among patients suffering from acute ischemia is a 
well-established observation. Both serious cardiac disease and reperfusion injury 
contribute to mortality [87].
Mortality from acute arterial occlusion are reported from 7 to 37% and the 
amputation rate in patients with embolism 10–30% [88, 89].
Acute myocardial infarction and arrhythmia are responsible for the majority of 
deaths and, despite advances in technology and clinical support, mortality among acute 
arterial occlusion patients remains high [8], particularly among the elderly [90]. One 
study demonstrated that New York Heart Association (NYHA) classification was the 
most important predictor for survival (class 3–4 had a 3.35 times higher death rate than 
class 1–2) [91]. Advanced age, recent myocardial infarction and proximal occlusions are 
also associated with a high mortality rate after arterial thromboembolectomy [92].
7.1 Compartment syndrome
After limb revascularization (particularly if ischemia is intense and prolonged) 
compartment syndrome may occur. This is due to edema increasing the pressure 
Absolute
1. Established cerebrovascular event (including transient ischemic attacks within last 2 months)
2. Active bleeding diathesis
3. Recent gastrointestinal bleeding (<10 days)
4. Neurosurgery (intracranial, spinal) within last 3 months
5. Intracranial trauma within last 3 months
Relative major
1. Cardiopulmonary resuscitation within last 10 days
2. Major nonvascular surgery or trauma within last 10 days
3. Uncontrolled hypertension: >180 mmHg systolic or >110 mmHg diastolic
4. Puncture of noncompressible vessel
5. Intracranial tumor
6. Recent eye surgery
Minor
1. Hepatic failure, particularly those with coagulopathy
2. Bacterial endocarditis
3. Pregnancy
4. Diabetic hemorrhagic retinopathy
Table 3. 
Thrombolysis contraindications.
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in muscle compartments situated between inelastic fascia and bones, which can 
compromise tissue perfusion. It may be caused by a chain of events secondary 
to ischemia-reperfusion, including with release of thromboxane A2 [8]. The 
ischemia-reperfusion phenomenon plays an important role in the pathogenesis of 
compartment syndrome due. Ischemia-reperfusion increases compartment volume 
by causing muscle tissue injury, which leads to increased microvascular perme-
ability, with efflux of plasma proteins and progressive interstitial edema [93]. With 
reperfusion, oxygen radical generation exacerbates microvascular permeability and 
resulting interstitial edema [94].
For diagnosis, some authors describe tissue pressures exceeding 30–45 mmHg 
[95, 96]. However, there are also authors who recommend diagnosis based on 
clinical criteria alone (spontaneous pain, pain on flexion or passive extension of the 
foot, tense edema, hypoperfusion, missing pulse, paresthesia, anesthesia, paresis, 
or paralysis) [8]. Risk factors for compartment syndrome after acute arterial isch-
emia includes prolonged ischemia time, young age, insufficient arterial collaterals, 
acute time course for arterial occlusion, hypotension and poor back-bleeding from 
the distal arterial tree at embolectomy [94].
Once a diagnosis of compartment syndrome has been made, fasciotomy should 
be conducted promptly, since it releases muscle compression, reestablishes capillary 
blood flow, and restores the caliber of arteries e veins. In general, this procedure 
is associated with low morbidity. The staged fasciotomy technique is generally 
sufficient to decompress the anterior and posterior compartments. If this does not 
provide sufficient relief of compression, 4-compartment fasciotomy should be 
performed via a wide incision. Incisions can be sutured after 1–2 weeks or heal by 
secondary intention [8].
7.2 Ischemia: reperfusion injury
This primarily occurs after ischemia of large muscle masses, which can develop 
local and systemic metabolic abnormalities after arterial desobstruction and 
reperfusion of ischemic tissues [97]. One study demonstrated a 7.5% incidence of 
this syndrome in patients with acute arterial occlusion, with 4.7% mortality [98].
Serious metabolic abnormalities can develop with ischemia of the lower limb 
muscle mass [99]. Ischemia compromises the integrity of the cell membrane and 
cause cellular dysfunction [100–102]. The reperfusion can exacerbate it, making the 
damage irreversible [103].
Tissue hypoxia results in movement of neutrophils and macrophages into the 
interstitium through the action of hypoxia adaptive pathways [104–106]. Activated 
neutrophils subsequently release molecular mediators, which contribute to the 
production of adenosine on the vascular endothelial surface, a protective factor that 
restores endothelial integrity [107, 108]. Activated leukocytes also have significant 
pro-inflammatory consequences. Neutrophils release factors that increase endothe-
lial permeability and cytoskeletal rearrangement [109].
During ischemia, the supply of oxygen to cells is reduced, decreasing aerobic 
metabolism and, consequently, reducing the energy available for maintenance 
of cellular metabolism [110]. In consequence of the reduced energy supply, the 
sodium-potassium-ATPase protein is affected and the sodium and potassium pump 
fails, resulting in cellular edema and ion flow disorders [111].
Oxygen free radicals are produced by molecular oxygen reintroduced into the isch-
emic tissue during reperfusion [102]. They can cause cell injury by reacting with poly-
saturated fatty acids, leading to peroxidation of lipid components in the membrane 
[112], which can rupture cell integrity [102] and attract leukocytes to the ischemic 
tissues. Reperfusion of ischemic tissue can have effects that are highly damaging to the 
13
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function of distant organs [113]. Data are emerging regarding the important role of 
the tumor necrosis factor-α (TNF-α), released from activated macrophages [114].
Serious pulmonary injuries, such as low oxygen tension, pulmonary edema, 
pulmonary hypertension and inflammatory response, can be caused by the activity 
of mediators such as free oxygen radicals, thromboxane, leukotrienes and neutro-
phils [115, 116].
Serum potassium levels can vary after revascularization. Hyperkalemia is a con-
sequence of myocytolysis and, in combination with acidosis, can lead to myocardial 
depression, hypotension, arrhythmia, and cardiac arrest. Renal dysfunction may 
occur, depending on the degree of metabolic acidosis, muscle injury, myoglobinuria 
and hypovolemia [117, 118].
Adjuvants measures can be useful to attenuate or avoid additional damage 
to cells during the reperfusion period. These measures include hypothermia, 
controlled reperfusion, and hemodilution [119]. In some cases, it can be useful to 
drain the effluent blood from the limb, immediately after revascularization, with 
the objective of removing toxic products that have built up during the period of 
ischemia [18]. Free radical scavengers still need to be further evaluated for their 
efficacy for reducing post-reperfusion cellular damage [120]. There is evidence that 
antioxidant vitamins and calcium channel blockers could be useful for attenuating 
ischemia-reperfusion cell damage [121]. Preventative measures for ischemia-reper-
fusion syndrome are alkalinization, osmotic diuresis and correction of hyperkale-
mia. Red blood cells can be washed, resuspended, and reinfused [122, 123],  
primarily in cases with muscle rigidity [122].
8. Future avenues/developments
Advances in this area are evident. For many years, there was no specific treat-
ment for lower limb embolism. The most serious cases were treated only with 
analgesia and amputation. The Fogarty catheter revolutionized the prognosis of 
these patients. Now, ever-greater advances are made, and even less invasive treat-
ments gain space.
The tendency is that endovascular treatment, including fibrinolysis and per-
cutaneous aspiration, evolves more and more, with the development of new and 
less invasive devices, and will probably be considered the treatment of choice for 
embolic occlusion of the lower limb.
9. Conclusion
Acute limb ischemia of the lower extremity is a potentially devastating condition 
that requires urgent and definitive management. The two principal etiologies of 
acute ischemia of the lower limbs are arterial embolism and in situ thrombosis of an 
atherosclerotic artery.
Despite major advances in the contemporary management of peripheral arte-
rial occlusive disease, acute ischemia of the lower limb is still characterized by an 
important morbidity, limb threat, mortality, and continues to pose a challenge to 
the vascular surgeon.
Atrial fibrillation, left ventricular aneurysm, penetrating ulcers or aneurysms 
of the aorta and common iliac arteries are the common sources of emboli. The 
presence of occlusion can be determined noninvasively with the use of duplex 
Doppler ultrasonography. If time permits, Arteriography, Computed Tomographic 
Angiography and Magnetic Resonance Angiography can also be employed.
Embolic Diseases - Evolving Diagnostic and Management Approaches
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